Frequently asked questions, January 2011

Frequently asked questions, January 2011

Answers to frequently-asked questions about HD – the first in a regular series of HDBuzz FAQ articles.

Professor Ed WildJanuary 07, 2011

Getting the data out – a new scientific journal just for HD

Getting the data out – a new scientific journal just for HD

New scientific journal PLoS Currents HD promises rapid publication & open access, improving scientific communication

Dr Michael OrthJanuary 04, 2011

Dimebon: disappointing in Alzheimer’s but might work in HD

Dimebon: disappointing in Alzheimer’s but might work in HD

Dimebon – disappointing results in an Alzheimer’s disease trial, but hope remains for HD.

Dr Jeff CarrollDecember 23, 2010

Focused drug screening leads to improved drugs to increase the rate of cellular recycling

Focused drug screening leads to improved drugs to increase the rate of cellular recycling

Advanced drug screening techniques help scientists to make drugs that increase cellular recycling in neurons.

Dr Jeff CarrollDecember 16, 2010

Does HD cause brains to develop differently?

Does HD cause brains to develop differently?

Smaller total brain volumes in male HD mutation carriers suggests brain development may be different in HD.

Dr Jeff CarrollDecember 06, 2010

Are there genetic connections between neurodegenerative diseases?

Are there genetic connections between neurodegenerative diseases?

Genetic evidence suggests connections between a polyQ disease and ALS (Lou Gehrig’s disease). Why should HD people ca

Dr Jeff CarrollDecember 01, 2010

Is Huntington’s disease twice as common as we thought?

Is Huntington’s disease twice as common as we thought?

New data suggest there may be twice as many people with HD symptoms as previously thought – and even more at risk

Professor Ed WildNovember 27, 2010

Two large HD observational studies – COHORT and Registry – merge to create ENROLL-HD

Two large HD observational studies – COHORT and Registry – merge to create ENROLL-HD

Merger of two major Huntington’s Disease observational trials creates ENROLL-HD

Dr Jeff CarrollNovember 24, 2010

Huntexil for symptoms of Huntington's disease: where are we now?

Huntexil for symptoms of Huntington's disease: where are we now?

Two clinical trials in Europe and the USA have suggested a new drug, Huntexil, might improve movements in HD. The nex

Professor Ed WildNovember 16, 2010

Minocycline: the end of the road?

Minocycline: the end of the road?

DOMINO clinical trial result: minocycline doesn’t slow down HD and shouldn’t be studied in larger trials.

Professor Ed WildNovember 10, 2010

TRACK-HD reveals significant changes in pre-symptomatic HD mutation carriers and patients

TRACK-HD reveals significant changes in pre-symptomatic HD mutation carriers and patients

The one-year report from the TRACK-HD study demonstrates a number of changes in pre-symptomatic HD-mutation carriers

Dr Jeff CarrollNovember 01, 2010

Donate

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community.

With your support, we can ensure the continuity of our services. Nothing is expected, but everything is appreciated and sustains what we do at HDBuzz. Please consider giving what you're able. More information...